CoChat

High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis

Open access

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

AIMS: High-sensitivity cardiac troponin I (cTnI) assays hold promise in detecting the transition from hypertrophy to heart failure in aortic stenosis. We sought to investigate the mechanism for troponin release in patients with aortic stenosis and whether plasma cTnI concentrations are associated with long-term outcome. METHODS AND RESULTS: Plasma cTnI concentrations were measured in two patient cohorts using a high-sensitivity assay. First, in the Mechanism Cohort, 122 patients with aortic stenosis (median age 71, 67% male, aortic valve area 1.0 ± 0.4 cm(2)) underwent cardiovascular magnetic resonance and echocardiography to assess left ventricular (LV) myocardial mass, function, and fibrosis. The indexed LV mass and measures of replacement fibrosis (late gadolinium enhancement) were associated with cTnI concentrations independent of age, sex, coronary artery disease, aortic stenosis severity, and diastolic function. In the separate Outcome Cohort, 131 patients originally recruited into the Scottish Aortic Stenosis and Lipid Lowering Trial, Impact of REgression (SALTIRE) study, had long-term follow-up for the occurrence of aortic valve replacement (AVR) and cardiovascular deaths. Over a median follow-up of 10.6 years (1178 patient-years), 24 patients died from a cardiovascular cause and 60 patients had an AVR. Plasma cTnI concentrations were associated with AVR or cardiovascular death HR 1.77 (95% CI, 1.22 to 2.55) independent of age, sex, systolic ejection fraction, and aortic stenosis severity. CONCLUSIONS: In patients with aortic stenosis, plasma cTnI concentration is associated with advanced hypertrophy and replacement myocardial fibrosis as well as AVR or cardiovascular death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehu189

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Comparison of two patients with severe aortic stenosis. Both had similar severity of aortic valve narrowing (peak aortic jet velocity in Patient A was 4.8 m/s and Patient B 5.1 m/s) and neither had significant coronary artery disease. However, the high-sensitivity troponin I concentration was more than four-fold higher in Patient A (11.9 ng/L) compared with Patient B (2.5 ng/L), consistent with the more advanced hypertrophic response observed in this patient (left ventricular mass index in Patient A was 114 g/m2 and Patient B was 81 g/m2). Furthermore, Patient A had evidence of focal mid-wall fibrosis on late gadolinium imaging (LGE) and myocardial T1 mapping (Patient B did not) and more extensive collagen staining with picrosirius red staining on myocardial biopsy.
Figure 1 Comparison of two patients with severe aortic stenosis. Both had similar severity of aortic valve narrowing (peak aortic jet velocity in Patient A was 4.8 m/s and Patient B 5.1 m/s) and neither had significant coronary artery disease. However, the high-sensitivity troponin I concentration was more than four-fold higher in Patient A (11.9 ng/L) compared with Patient B (2.5 ng/L), consistent with the more advanced hypertrophic response observed in this patient (left ventricular mass index in Patient A was 114 g/m2 and Patient B was 81 g/m2). Furthermore, Patient A had evidence of focal mid-wall fibrosis on late gadolinium imaging (LGE) and myocardial T1 mapping (Patient B did not) and more extensive collagen staining with picrosirius red staining on myocardial biopsy.CC BY-NC · PubMed Central
Figure 2 Correlation between indexed left ventricular mass and plasma cardiac troponin I concentrations (log-transformed). Similar correlation was seen in patients with (A) and without (B) coronary artery disease.
Figure 2 Correlation between indexed left ventricular mass and plasma cardiac troponin I concentrations (log-transformed). Similar correlation was seen in patients with (A) and without (B) coronary artery disease.CC BY-NC · PubMed Central
Figure 3 Patients with aortic stenosis and mid-wall late gadolinium enhancement (LGE) had a two-fold increase in cardiac troponin I concentrations compared with those without LGE and age- and sex-matched healthy patients.
Figure 3 Patients with aortic stenosis and mid-wall late gadolinium enhancement (LGE) had a two-fold increase in cardiac troponin I concentrations compared with those without LGE and age- and sex-matched healthy patients.CC BY-NC · PubMed Central
Figure 4 Ten-year event-free survival for composite endpoint of aortic valve replacement or cardiovascular death by tertiles of cardiac troponin I concentrations. Patients in the highest tertile were associated with lower survival rates compared with patients in the other tertiles (log rank test for trend, P = 0.016).
Figure 4 Ten-year event-free survival for composite endpoint of aortic valve replacement or cardiovascular death by tertiles of cardiac troponin I concentrations. Patients in the highest tertile were associated with lower survival rates compared with patients in the other tertiles (log rank test for trend, P = 0.016).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 2

  1. Wieczorek, 2002, American heart journal, 144, 834, 10.1067/mhj.2002.125623 · doi:10.1067/mhj.2002.125623 · Paper page
  2. 2013, Journal of the American College of Cardiology, 26, 1240

Cited by

See all 263

Metadata

Authors
Chin, C. W. L., Shah, A. S. V., McAllister, D. A., Joanna Cowell, S., Alam, S., Langrish, J. P., Strachan, F. E., Hunter, A. L., Maria Choy, A., Lang, C. C., Walker, S., Boon, N. A., Newby, D. E., Mills, N. L., & Dweck, M. R.
Affiliations
  • National Heart Centre Singapore (SG)
  • University of Edinburgh (GB)
  • Ninewells Hospital (GB)
  • Edinburgh Royal Infirmary (GB)
Corresponding author
Chin, C. W. L.
Venue
European Heart Journal
Published
2014-05-14
Volume
35
Issue
34
Pages
2312-2321
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2105249780
Cited by
233
References
25
Citations by year
2026: 7 · 2025: 10 · 2024: 16 · 2023: 17 · 2022: 25 · 2021: 20 · 2020: 24 · 2019: 25 · 2018: 18 · 2017: 29 · 2016: 25 · 2015: 11 · 2014: 6
FWCI
16.23
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • European Heart Journal (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
Funders
  • Abbott Laboratories
  • Wellcome Trust (CH/09/002)
  • British Heart Foundation (FS/12/83/29781, CH09/002, FS/13/77/30488, SS/CH/09/002, FS/14/78/31020, FS/10/024, FS/10/024/28266, SP/12/10/29922)
  • National Research Foundation
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
aortic stenosis, high-sensitivity troponin I, left ventricular hypertrophy, myocardial fibrosis, late gadolinium enhancement, aortic valve replacement, cardiovascular mortality, troponin release, left ventricular mass, cardiovascular magnetic resonance
MeSH terms
Aged, Aortic Valve Stenosis, Biological Assay, Contrast Media, Female, Fibrosis, Follow-Up Studies, Heart Failure, Humans, Male, Myocardium, Organometallic Compounds, Prognosis, Stroke Volume, Tomography, X-Ray Computed, Biomarkers, Hypertrophy, Left Ventricular, Magnetic Resonance Angiography, Troponin I, Heart Valve Prosthesis Implantation, Natriuretic Peptide, Brain, Early Diagnosis, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. https://app.cochat.ai/papers/10.1093/eurheartj/ehu189
The paper
Chin, C. W. L., Shah, A. S. V., McAllister, D. A., Joanna Cowell, S., Alam, S., Langrish, J. P., Strachan, F. E., Hunter, A. L., Maria Choy, A., Lang, C. C., Walker, S., Boon, N. A., Newby, D. E., Mills, N. L., & Dweck, M. R. (2014). High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. European Heart Journal. https://doi.org/10.1093/eurheartj/ehu189

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.